|
NHLRC2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.96598293200623E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.02299996146616E-09 |
| Normal-vs-Stage2 |
3.94439999551466E-08 |
| Normal-vs-Stage3 |
1.20449983320725E-10 |
| Normal-vs-Stage4 |
1.64890001652651E-09 |
| Stage1-vs-Stage2 |
3.059600E-01 |
| Stage1-vs-Stage3 |
2.334100E-02 |
| Stage1-vs-Stage4 |
7.582200E-02 |
| Stage2-vs-Stage3 |
6.186600E-01 |
| Stage2-vs-Stage4 |
7.062200E-01 |
| Stage3-vs-Stage4 |
9.368200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.42770240074697E-11 |
| Normal-vs-AfricanAmerican |
1.041850E-03 |
| Normal-vs-Asian |
2.64980000164172E-08 |
| Caucasian-vs-AfricanAmerican |
3.860400E-01 |
| Caucasian-vs-Asian |
3.846600E-01 |
| AfricanAmerican-vs-Asian |
1.651240E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.1154966667325E-11 |
| Normal-vs-Female |
2.19300022585855E-10 |
| Male-vs-Female |
4.723600E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.3861999981788E-08 |
| Normal-vs-Age(41-60Yrs) |
6.59194920871187E-12 |
| Normal-vs-Age(61-80Yrs) |
1.68519997956196E-09 |
| Normal-vs-Age(81-100Yrs) |
8.794500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.284200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.021770E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.803800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.447800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.133200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.439800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.198000E-02 |
| Classical-VS-Follicular |
2.315600E-01 |
| Classical-VS-Other |
1.757210E-01 |
| Classical-VS-Normal |
6.92199630947243E-11 |
| Tall-VS-Follicular |
3.274000E-01 |
| Tall-VS-Other |
5.367400E-01 |
| Tall-VS-Normal |
1.21940002539844E-09 |
| Follicular-VS-Other |
4.204600E-01 |
| Follicular-VS-Normal |
2.04660000058254E-08 |
| Other-VS-Normal |
6.575100E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.09134923320653E-13 |
| Normal-vs-N1 |
1.4738999998265E-07 |
| N0-vs-N1 |
9.423600E-01 |
|
|
